Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8073423 | 0.98 | CYP1A2 (0.46) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL15303105 | 0.87 | CYP1A2 (0.52) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL7853433 | 0.80 | CYP1A2 (0.44) | CYP1A2CYP2D6 | |
| SCHEMBL28829996 | 0.80 | CYP1A2 (0.44) | CYP1A2CYP2D6 | |
| SCHEMBL28042099 | 0.79 | CYP1A2 (0.50) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL28709853 | 0.79 | CYP1A2 (0.43) | CYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL7737390 | 0.79 | CYP1A2 (0.61) | CYP1A2CYP2D6 | |
| SCHEMBL7986350 | 0.78 | CYP1A2 (0.48) | CYP1A2CYP2D6 | |
| SCHEMBL3164457 | 0.78 | — | — | |
| SCHEMBL27963869 | 0.76 | CYP1A2 (0.47) | CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0649536-B1 | ASSAY FOR CHAGAS' DISEASE AND REAGENTS FOR ITS USE | ABBOTT LAB (US) | 2002-04-24 | — | — | EP | claimed |
| EP-0203959-B1 | NUCLEOTIDE ANALOGS FOR NUCLEIC ACID LABELING AND DETECTION | LIFE TECHNOLOGIES, INC. (US) | 1992-09-09 | — | — | EP | claimed |
| EP-3619242-A1 | METHOD FOR PRODUCING HYDROGEL FROM MODIFIED HYALURONIC ACID AND TYPE 1 COLLAGEN | HCS Pharma (FR) | 2020-03-11 | — | — | EP | disclosed |
| WO-2016166479-A1 | METHOD FOR PRODUCING HYDROGEL FROM MODIFIED HYALURONIC ACID AND TYPE 1 COLLAGEN | CELENYS (FR) | 2016-10-20 | — | — | WO | disclosed |
| EP-2653164-A1 | Type 5 and type 8 capsular polysaccharides of over-productive strains of S. aureus | Sanofi Pasteur (FR) | 2013-10-23 | — | — | EP | disclosed |
| EP-2004223-A1 | TYPE 5 AND TYPE 8 CAPSULAR POLYSACCHARIDES OF SUPERPRODUCING STAPHYLOCOCCUS AUREUS STRAINS | Sanofi Pasteur (FR) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007118979-A1 | TYPE 5 AND TYPE 8 CAPSULAR POLYSACCHARIDES OF SUPERPRODUCING STAPHYLOCOCCUS AUREUS STRAINS | SANOFI PASTEUR (FR) | 2007-10-25 | — | — | WO | disclosed |
| JP-2003180815-A | RESORBABLE EXTRACELLULAR MATRIX CONTAINING COLLAGEN I AND COLLAGEN II FOR RECONSTRUCTION OF CARTILAGE | ED GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE | 2003-07-02 | — | — | JP | disclosed |